Coherus: Interchangeability ‘A Melting Ice Cube,’ Price And Supply Key

FDA-Approved Yusimry Biosimilar Device ‘Will Look Nearly Identical’

 
• By Dean Rudge
  
Ice Cube Melting
Coherus wants to capture at least a 10% volume share • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products